本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cogent Biosciences, Inc.

33.53
+0.12000.36%
成交量:44.03萬
成交額:1,464.05萬
市值:58.18億
市盈率:-15.52
高:33.58
開:33.42
低:32.85
收:33.41
52周最高:43.73
52周最低:11.60
股本:1.74億
流通股本:1.67億
量比:0.65
換手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
淨資產收益率:-109.74%
總資產收益率:-43.84%
市淨率:12.44
市盈率(LYR):-13.15

資料載入中...

2024/12/09

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

SEC問詢函

Form CORRESP - Correspondence
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]